Menu

Practices

Gritstone bio Inc.

The firm is bankruptcy counsel to Gritstone bio, a publicly held company previously listed on NASDAQ, in its chapter 11 case. Gritstone bio is a clinical-stage biotechnology company, focused on developing next-generation vaccines aimed at treating cancers as welll as treating and preventing infectious diseases by leveraging its proprietary technology platforms. With the firm's assistance, the debtor is exploring strategic and transactional alternatives to maximize value for all stakeholders.

Our website uses cookies to enhance site navigation, analyze site usage, and assist in our marketing efforts. By continuing to browse this website, you agree to our Privacy Policy.